Andrew Balo
2019
In 2019, Andrew Balo earned a total compensation of $3M as EVP, Regulatory Strategy, Clinical Affairs, and Strategic Partnership Development at DexCom, a 5% decrease compared to previous year.
Compensation breakdown
| Bonus | $7,500 |
|---|---|
| Non-Equity Incentive Plan | $461,160 |
| Salary | $384,300 |
| Stock Awards | $2,146,723 |
| Other | $23,007 |
| Total | $3,022,690 |
Balo received $2.1M in stock awards, accounting for 71% of the total pay in 2019.
Balo also received $7.5K in bonus, $461.2K in non-equity incentive plan, $384.3K in salary and $23K in other compensation.
Rankings
In 2019, Andrew Balo's compensation ranked 4,055th out of 13,971 executives tracked by ExecPay. In other words, Balo earned more than 71.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,055 out of 13,971 | 71st |
Division Manufacturing | 1,465 out of 5,698 | 74th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 202 out of 832 | 76th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 115 out of 535 | 79th |
Industry Surgical and Medical Instruments and Apparatus | 71 out of 350 | 80th |
Pay ratio
| Andrew Balo's Pay | $3,022,690 |
|---|---|
| Median Employee's Pay | $94,523 |
| Pay Ratio | 32to 1 |
In 2019, the annual total compensation of Andrew Balo was $3,022,690.
The annual total compensation of the median employee at DexCom was $94,523.
The ratio of Andrew Balo's pay to the pay of median employee was therefore 32 to one.
Source: SEC filing on April 10, 2020.
Balo's colleagues
We found four more compensation records of executives who worked with Andrew Balo at DexCom in 2019.